Ethoxy-2-aminoethoxyl-O-(alpha-L-idopyranosyl uronic acid-alpha(1->4)-alpha-L-idopyranosyl uronic acid-alpha(1->4)-alpha-L-idopyranosyl uronic acid-alpha(1->4))-alpha-L-idopyranoside uronic acid

ID: ALA5084390

Chembl Id: CHEMBL5084390

PubChem CID: 166633453

Max Phase: Preclinical

Molecular Formula: C28H43NO26

Molecular Weight: 809.63

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  NCCOCCO[C@@H]1O[C@@H](C(=O)O)[C@@H](O[C@@H]2O[C@@H](C(=O)O)[C@@H](O[C@@H]3O[C@@H](C(=O)O)[C@@H](O[C@@H]4O[C@@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O

Standard InChI:  InChI=1S/C28H43NO26/c29-1-2-47-3-4-48-25-11(36)7(32)14(18(53-25)22(41)42)50-27-13(38)9(34)16(20(55-27)24(45)46)51-28-12(37)8(33)15(19(54-28)23(43)44)49-26-10(35)5(30)6(31)17(52-26)21(39)40/h5-20,25-28,30-38H,1-4,29H2,(H,39,40)(H,41,42)(H,43,44)(H,45,46)/t5-,6-,7+,8+,9+,10+,11+,12+,13+,14-,15-,16-,17+,18+,19+,20+,25+,26+,27+,28+/m0/s1

Standard InChI Key:  XLLOQUXCLFGRHW-JCOSJTSTSA-N

Alternative Forms

  1. Parent:

    ALA5084390

    ---

Associated Targets(Human)

CXCL8 Tchem Interleukin-8 (642 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCL5 Tchem C-C motif chemokine 5 (54 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCL7 Tbio C-C motif chemokine 7 (13 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CXCL10 Tbio C-X-C motif chemokine 10 (13 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CXCL12 Tchem Stromal cell-derived factor 1 (156 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCL2 Tchem C-C motif chemokine 2 (131 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 809.63Molecular Weight (Monoisotopic): 809.2073AlogP: -9.38#Rotatable Bonds: 16
Polar Surface Area: 440.36Molecular Species: ZWITTERIONHBA: 23HBD: 14
#RO5 Violations: 3HBA (Lipinski): 27HBD (Lipinski): 15#RO5 Violations (Lipinski): 3
CX Acidic pKa: 2.48CX Basic pKa: 9.44CX LogP: -9.77CX LogD: -19.86
Aromatic Rings: Heavy Atoms: 55QED Weighted: 0.06Np Likeness Score: 0.72

References

1. Shanthamurthy CD, Leviatan Ben-Arye S, Kumar NV, Yehuda S, Amon R, Woods RJ, Padler-Karavani V, Kikkeri R..  (2021)  Heparan Sulfate Mimetics Differentially Affect Homologous Chemokines and Attenuate Cancer Development.,  64  (6.0): [PMID:33683903] [10.1021/acs.jmedchem.0c01800]

Source